AI assistant
ON24 INC. — Director's Dealing 2023
Jun 9, 2023
33490_dirs_2023-06-09_737c49f6-b761-4d1a-83cf-62af77e4caa9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ON24 INC. (ONTF)
CIK: 0001110611
Period of Report: 2023-06-09
Reporting Person: Sharan Sharat (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 362607.00 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $13.33 | 2030-12-11 | Common Stock (20802.00) | 20802.00 | Direct |
| Stock Options (Right to buy) | $13.33 | 2030-12-11 | Common Stock (439198.00) | 439198.00 | Direct |
| Stock Options (Right to buy) | $2.00 | 2030-03-15 | Common Stock (99836.00) | 99836.00 | Direct |
| Stock Options (Right to buy) | $1.70 | 2026-01-04 | Common Stock (78863.00) | 78863.00 | Direct |
| Stock Options (Right to buy) | $1.68 | 2023-09-16 | Common Stock (1484.00) | 1484.00 | Direct |
| Stock Options (Right to buy) | $1.68 | 2024-08-07 | Common Stock (154400.00) | 154400.00 | Direct |
| Stock Options (Right to buy) | $1.35 | 2028-12-21 | Common Stock (427950.00) | 427950.00 | Direct |
| Stock Options (Right to buy) | $1.23 | 2030-03-15 | Common Stock (313794.00) | 313794.00 | Direct |
| Stock Options (Right to buy) | $0.89 | 2026-01-04 | Common Stock (409201.00) | 409201.00 | Direct |
| Stock Options (Right to buy) | $0.86 | 2023-09-16 | Common Stock (108718.00) | 108718.00 | Direct |
| Stock Options (Right to buy) | $0.86 | 2024-08-07 | Common Stock (66666.00) | 66666.00 | Direct |
| Stock Options (Right to buy) | $0.86 | 2025-07-24 | Common Stock (497642.00) | 497642.00 | Direct |
Footnotes
F1: The Reporting Person is voluntarily restating his holdings in light of the $1.09 special dividend declared on May 8, 2023, payable on or about June 15, 2023, to stockholders of record as of the close of business on May 22, 2023. Pursuant to antidilution provisions, the previously awarded restricted stock units ("RSUs") with 312,954 outstanding were automatically adjusted to represent RSUs to acquire 362,607 shares, as reflected herein. There were no other changes to the RSUs.
F2: The RSUs will vest quarterly in 12 equal installments over a three-year period, with the first installment vesting on March 31, 2023, in each case subject to the Reporting Person's continued service through the applicable vesting date.
F3: Pursuant to antidilution provisions, the exercise price of $14.42 per share of the previously awarded options were automatically adjusted
to $13.33 per share, as reflected herein. There were no other changes to the options.
F4: The options vested with respect to 1/48th of such shares on February 1, 2021, with 1/48th of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F5: Pursuant to antidilution provisions, the previously awarded options to acquire 86,206 shares for an exercise
price of $2.32 per share were automatically adjusted to represent options to acquire 99,836 shares for an exercise
price of $2.00 per share, as reflected herein. There were no other changes to the options.
F6: The options vested with respect to 1/24th of such shares on January 1, 2021, with 1/24th of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F7: Pursuant to antidilution provisions, the previously awarded options to acquire 68,181 shares for an exercise
price of $1.98 per share were automatically adjusted to represent options to acquire 78,863 shares for an exercise
price of $1.70 per share, as reflected herein. There were no other changes to the options.
F8: The options are fully vested and exercisable.
F9: Pursuant to antidilution provisions, the previously awarded options to acquire 1,282 shares for an exercise
price of $1.95 per share were automatically adjusted to represent options to acquire 1,484 shares for an exercise
price of $1.68 per share, as reflected herein. There were no other changes to the options.
F10: Pursuant to antidilution provisions, the previously awarded options to acquire 133,334 shares for an exercise
price of $1.95 per share were automatically adjusted to represent options to acquire 154,400 shares for an exercise
price of $1.68 per share, as reflected herein. There were no other changes to the options.
F11: Pursuant to antidilution provisions, the exercise price of $2.44 per share of the previously awarded options were automatically adjusted to $1.35 per share, as reflected herein. There were no other changes to the options.
F12: Pursuant to antidilution provisions, the exercise price of $2.32 per share of the previously awarded options were automatically adjusted to $1.23 per share, as reflected herein. There were no other changes to the options.
F13: Pursuant to antidilution provisions, the exercise price of $1.98 per share of the previously awarded options were automatically adjusted to $0.89 per share, as reflected herein. There were no other changes to the options.
F14: Pursuant to antidilution provisions, the exercise price of $1.95 per share of the previously awarded options were automatically adjusted to $0.86 per share, as reflected herein. There were no other changes to the options.
F15: Pursuant to antidilution provisions, the exercise price of $1.95 per share of the previously awarded options were automatically adjusted
to $0.86 per share, as reflected herein. There were no other changes to the options.